Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Suzhou , Jiangsu
- Most recent report
- 6-K, filed Nov 5, 2026
- Incorporated
- N/A
- Filings on record
- 133 filings
- On EDGAR
- CIK 2023311
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Emerging growth company
Financials 8 of 80
- 6-K Report a foreign issuer made public elsewhere Nov 5, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 28, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 22, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 21, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 15, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 29, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 17, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 20, 2026
Prospectuses and Registrations 5
- S-8 Registration statement for an employee plan Sep 16, 2025
- S-8 POS Post-effective amendment to an employee plan registration Aug 28, 2025
- 424B4 Final prospectus for an offering Jan 24, 2025
- S-8 Registration statement for an employee plan Jan 24, 2025
- F-1 Registration statement, foreign issuer Dec 27, 2024
Ownership 8 of 26
- 3 Insider reported their initial holding Jun 29, 2026
- 4 Insider reported a trade May 22, 2026
- 4 Insider reported a trade May 22, 2026
- 4 Insider reported a trade Apr 21, 2026
- 3 Insider reported their initial holding Apr 21, 2026
- 3/A Insider reported their initial holding, amended Apr 20, 2026
- 3 Insider reported their initial holding Apr 10, 2026
- 3 Insider reported their initial holding Mar 23, 2026
Other 8 of 22
- F-3ASR Jul 20, 2026
- 6-K/A Report a foreign issuer made public elsewhere, amended Apr 24, 2025
- 6-K/A Report a foreign issuer made public elsewhere, amended Mar 26, 2025
- SEC STAFF LETTER Jan 24, 2025
- EFFECT Notice that a registration became effective Jan 23, 2025
- CERT Exchange certified a listing Jan 23, 2025
- 8-A12B Registration of a security for exchange listing Jan 21, 2025
- CORRESP Reply to SEC staff Jan 21, 2025
Everything here comes from Ascentage Pharma Group International's own filings on SEC EDGAR. The filing list is rechecked every hour.